CN110169577A - 一种火龙果皮组合物口服剂 - Google Patents
一种火龙果皮组合物口服剂 Download PDFInfo
- Publication number
- CN110169577A CN110169577A CN201910640462.2A CN201910640462A CN110169577A CN 110169577 A CN110169577 A CN 110169577A CN 201910640462 A CN201910640462 A CN 201910640462A CN 110169577 A CN110169577 A CN 110169577A
- Authority
- CN
- China
- Prior art keywords
- slurries
- pitaya peel
- corn stigma
- mixed
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000010837 Echinocereus enneacanthus subsp brevispinus Nutrition 0.000 title claims abstract description 59
- 235000006850 Echinocereus enneacanthus var dubius Nutrition 0.000 title claims abstract description 59
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 240000008086 Echinocereus enneacanthus Species 0.000 title claims abstract 15
- 240000008042 Zea mays Species 0.000 claims abstract description 59
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 55
- 239000002002 slurry Substances 0.000 claims abstract description 54
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 52
- 235000005822 corn Nutrition 0.000 claims abstract description 52
- 240000006995 Abutilon theophrasti Species 0.000 claims abstract description 33
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 31
- 239000007788 liquid Substances 0.000 claims abstract description 29
- 210000002966 serum Anatomy 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000843 powder Substances 0.000 claims abstract description 15
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 235000012907 honey Nutrition 0.000 claims abstract description 11
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 230000036772 blood pressure Effects 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 5
- 235000014347 soups Nutrition 0.000 claims abstract description 4
- 244000157072 Hylocereus undatus Species 0.000 claims description 57
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
- 235000018481 Hylocereus undatus Nutrition 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 9
- 235000019441 ethanol Nutrition 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 206010020772 Hypertension Diseases 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 230000001631 hypertensive effect Effects 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 230000035800 maturation Effects 0.000 claims description 5
- 235000007244 Zea mays Nutrition 0.000 claims description 4
- 238000010411 cooking Methods 0.000 claims description 4
- 229940089639 cornsilk Drugs 0.000 claims description 4
- 235000015203 fruit juice Nutrition 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000003860 storage Methods 0.000 claims description 4
- 239000001231 zea mays silk Substances 0.000 claims description 4
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000004438 eyesight Effects 0.000 abstract description 6
- 235000013402 health food Nutrition 0.000 abstract description 5
- 239000006210 lotion Substances 0.000 abstract description 4
- 229930014669 anthocyanidin Natural products 0.000 abstract description 3
- 150000001452 anthocyanidin derivatives Chemical class 0.000 abstract description 3
- 235000008758 anthocyanidins Nutrition 0.000 abstract description 3
- WNQQFQRHFNVNSP-UHFFFAOYSA-N [Ca].[Fe] Chemical compound [Ca].[Fe] WNQQFQRHFNVNSP-UHFFFAOYSA-N 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 238000005292 vacuum distillation Methods 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 235000020339 pu-erh tea Nutrition 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000009973 maize Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 235000014786 phosphorus Nutrition 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- 206010029240 Neuritis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 201000003465 angular cheilitis Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 208000007287 cheilitis Diseases 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000015177 dried meat Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004436 pseudomyopia Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 208000025301 tympanitis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- LTVDFSLWFKLJDQ-UHFFFAOYSA-N α-tocopherolquinone Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O LTVDFSLWFKLJDQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明属于保健食品制备技术领域，涉及一种火龙果皮组合物口服剂；其各原料重量配比为：混合浆液：老酒浆液：蜂蜜：玉米须液＝10:5‑6:2:10‑15；先将火龙果皮用粉碎机粉碎成浆液，把浆液用重量百分比浓度35％乙醇水溶液溶解制得混合浆液备用，再将粉碎后的苘麻籽包浆液与即墨老酒混合制得老酒浆液备用，然后将烘干的玉米须研磨成粉末，将玉米须粉末用水熬煮后过滤制得玉米须液备用，最后将混合浆液、老酒浆液、蜂蜜和玉米须液混合减压蒸馏浓缩，制得火龙果皮组合物口服剂；所述火龙果皮组合物口服剂的制备工艺简单，产品服用方便，使用的原料纯天然，其中火龙果皮含有花青素、维生素及钙铁等营养物质，美容养颜，保护视力，调节血压，深得广大消费者的喜爱。
Description
技术领域：
本发明属于保健食品制备技术领域，涉及一种以火龙果皮为主要原料的保健食品组合物，具体涉及一种火龙果皮组合物口服剂。
背景技术：
火龙果皮不仅含有丰富的碳水化合物、蛋白质和花青素，还含有浓度很高的维生素A、B1、B2、B3、C及钙、磷、铁等矿物质，营养价值高，但是在日常生活中却被人们忽略，火龙果皮往往被弃置，造成资源浪费；并且火龙果皮具有抗氧化、抗自由基、抗衰老的作用，还具有抑制脑细胞变性，预防痴呆症的作用，火龙果皮含有的植物性白蛋白能够自动与人体内的重金属离子结合，通过排泄系统排出体外，从而起解毒的作用；除此之外，火龙果皮的营养成份对美白皮肤、预防便秘、促进眼睛保健、增加骨质密度、帮助细胞膜形成、预防贫血和抗神经炎及口角炎等炎症具有良好的效果，是一种营养价值极高的保健食品。
苘麻为锦葵科植物，我国除青藏高原不产外，其他各地均有种植或自然生产，苘麻具有清热利湿，解毒开窍之功效，常用于治疗痢疾、中耳炎、耳鸣、耳聋、睾丸炎、化脓性扁桃体炎和痈疽肿毒；玉米的营养成分比较全面，含有蛋白质、脂肪、糖类、钙、磷、铁等营养物质，还含有胡萝卜素、维生素B1、B2和尼克酸以及谷固醇、卵磷脂、维生素E、赖氨酸等，最新研究指出：玉米中含有一种杭癌因子—谷胱甘肽，具有明显的防癌效果；玉米须含有隐黄质、泛酸、肌醇、谷甾醇、豆甾醇、维生素C、苹果酸枸橼酸、草酸和酒石酸，还含脂肪油、挥发油、树胶、苦味糖苷和α-生育醌等，具有利尿、降压、降血糖、降血脂和利胆作用。
目前，在现有技术中，公开号为CN104663945B的中国专利，公开了一种火龙果皮茶及其制备方法，将火龙果皮、醋酸水与生物酶混合物按重量比为10-15:80-90:1-2的配比制备火龙果皮汁，然后将普洱茶、水与抗坏血酸按重量比为6-10:90-95:0.05-0.1的配比制备普洱茶汁，最后将火龙果皮汁和普洱茶汁混合，加入牛奶粉、扇贝粉、糖粉和柠檬酸等混合后离心均质制得火龙果皮茶，将热带特色水果火龙果皮独特的清香味与普洱茶的保健作用有机结合，具有保健良好的保健效果，但是火龙果皮的利用率低，仅有部分溶解的营养物质被利用；公开号为CN108094650A的中国专利，公开了一种低糖火龙果皮果脯加工方法，将火龙果皮清洗，削除鳞片，切成条备用，将得到的果皮条浸泡消毒液中消毒，将消毒后的果皮浸泡于复合糖液中，将浸糖后的果皮干燥封装，既得低糖火龙果皮果脯，制备的火龙果皮果脯，色泽紫红，均匀一致，饱满度好，不粘手，无破裂，透甜酸度适中，无异味，软硬适中，有嚼劲，但是本方法工艺过于简单，火龙果皮的营养成分未被提取浓缩，保健效果不佳。
总而言之，目前市场上存在的火龙果皮产品存在利用率低、加工工艺不完善，保健效果不佳的缺点；因此发明一种工艺完善，美容养颜，保护视力，有利于消除炎症的火龙果皮组合物食品很有应用前景。
发明内容：
本发明的发明目的在于克服现有火龙果皮产品利用率低、加工工艺不完善和效果不佳的缺点，寻求设计一种利用火龙果皮、苘麻籽包和蜂蜜为主要原料制备火龙果皮组合物口服剂。
为了实现上述目的，本发明涉及的一种火龙果皮组合物口服剂，其各原料重量配比为：混合浆液：老酒浆液：蜂蜜：玉米须液＝10:5-6:2:10-15；其中混合浆液由火龙果皮浆液与重量百分比浓度35％的乙醇水溶液按1:5重量比制得，老酒浆液由苘麻籽包浆液与即墨老酒按1:3的重量配比混合制得，玉米须液由玉米须粉与水按1:50重量配比蒸煮浓缩后过滤制得；所述的火龙果皮为鲜质的红色火龙果去肉后的皮层物，所述的鲜苘麻籽包为苘麻开花后10-20天期间内形成的伞状鲜质苘麻籽带壳包。
本发明所述的一种火龙果皮组合物口服剂，其具体制备工艺为：
(1)火龙果皮预处理：将鲜火龙果皮洗净，控温20℃内用粉碎机粉碎成浆液，然后将浆液与重量百分比浓度35％的乙醇水溶液按1:5重量比混合，搅拌均匀，控温20℃内静置30-36小时，静置过程中每隔5小时搅拌一次，得混合浆液；
(2)老酒浆液制备：将3-5成熟的鲜苘麻籽包在常温常压下与30-40℃的温水按1:1的重量比混合，然后放入果汁机中粉碎成苘麻籽包浆液，最后向苘麻籽包浆液中加入苘麻籽包浆液3倍重量的即墨老酒，搅拌均匀，制得老酒浆液；
(3)玉米须液制备：取新鲜玉米须清洗干净后放入烘箱中控温100-120℃烘烤20-30分钟，取出烘干的玉米须冷却后用研磨机研磨成粉，过200目筛网制得玉米须粉，将玉米须粉与水按1:50的重量配比放入铁锅中大火熬制，煮沸后熬制20-30分钟至溶液总体积缩减至原总体积的1/2，将蒸煮液冷却后过滤，收取滤液即为玉米须液；
(4)组合物混合液制备：在常温无氧环境下取混合浆液、老酒浆液、蜂蜜和玉米须液按10:5-6:2:10-15重量比搅拌混合均匀，控温15-20℃密封存储，制得组合物混合液；
(5)火龙果皮组合物口服剂制备：将组合物混合液放入反应锅中控温20℃内在1.3-1.6KPa条件下减压蒸馏，收取乙醇并回收利用，当组合物混合液中乙醇浓度蒸馏至低于重量百分比浓度1％时，停止蒸馏制得火龙果皮组合物口服剂，在常温无氧环境下密封保存。
本发明所述的火龙果组合物口服剂能够用于调节血压，高血压患者每日服用三次，每次直接口服20-40g,2-3周后血压控制良好，6-8周后，82％的高血压患者情况明显改善。
本发明与现有技术相比，所设计的火龙果皮组合物口服剂的制备工艺简单，营养搭配科学合理，产品服用方便，使用的原料纯天然，对人体无损害，其中火龙果皮含有花青素、维生素A、B1、及钙、磷、铁等营养物质，美容养颜，保护视力，调节血压，绿色无添加剂，深得广大消费者的喜爱。
具体实施方式：
下面通过实施例对本发明作进一步描述。
实施例1
本实施例涉及的一种火龙果皮组合物口服剂，其各原料重量配比为：混合浆液：老酒浆液：蜂蜜：玉米须液＝10:5-6:2:10-15；其中混合浆液由火龙果皮浆液与重量百分比浓度35％的乙醇水溶液按1:5重量比制得，老酒浆液由苘麻籽包浆液与即墨老酒按1:3的重量配比混合制得，玉米须液由玉米须粉与水按1:50重量配比蒸煮浓缩后过滤制得；本实施例所述的火龙果皮为鲜质的红色火龙果去肉后的皮层物，所述的鲜苘麻籽包为苘麻开花后10-20天期间内形成的伞状鲜质苘麻籽带壳包。
本实施例涉及的火龙果皮组合物口服剂的具体制备工艺为：
(1)火龙果皮预处理：将鲜火龙果皮洗净，控温20℃内用粉碎机粉碎成浆液，然后将浆液与重量百分比浓度35％的乙醇水溶液按1:5重量比混合，搅拌均匀，控温20℃内静置30-36小时，静置过程中每隔5小时搅拌一次，得混合浆液；
(2)老酒浆液制备：将3-5成熟的鲜苘麻籽包在常温常压下与30-40℃的温水按1:1的重量比混合，然后放入果汁机中粉碎成苘麻籽包浆液，最后向苘麻籽包浆液中加入苘麻籽包浆液3倍重量的即墨老酒，搅拌均匀，制得老酒浆液；
(3)玉米须液制备：取新鲜玉米须清洗干净后放入烘箱中控温100-120℃烘烤20-30分钟，取出烘干的玉米须冷却后用研磨机研磨成粉，过200目筛网制得玉米须粉，将玉米须粉与水按1:50的重量配比放入铁锅中大火熬制，煮沸后熬制20-30分钟至溶液总体积缩减至原总体积的1/2，将蒸煮液冷却后过滤，收取滤液即为玉米须液；
(4)组合物混合液制备：在常温无氧环境下取混合浆液、老酒浆液、蜂蜜和玉米须液按10:5-6:2:10-15重量比搅拌混合均匀，控温15-20℃密封存储，制得组合物混合液；
(5)火龙果皮组合物口服剂制备：将组合物混合液放入反应锅中控温20℃内在1.3-1.6KPa条件下减压蒸馏，收取乙醇并回收利用，当组合物混合液中乙醇浓度蒸馏至低于重量百分比浓度1％时，停止蒸馏制得火龙果皮组合物口服剂，在常温无氧环境下密封保存。
本实施例涉及的火龙果组合物口服剂能够用于调节血压，高血压患者每日服用三次，每次直接口服20-40g,2-3周后血压控制良好，6-8周后，大部分的高血压患者情况明显改善。
实施例2
本实施例涉及的火龙果皮组合物口服剂，其各原料重量配比为：混合浆液：老酒浆液：蜂蜜：玉米汁：玉米须液＝15-20:5-6:2:6-8:10-15；其中混合浆液由火龙果皮浆液与重量百分比浓度35％的乙醇水溶液按1:5重量比制得，老酒浆液由苘麻籽包浆液与即墨老酒按1:3的重量配比混合制得，玉米汁由熟玉米粒与水按1:2重量配比混合制得，玉米须液由玉米须粉与水按1:50重量配比蒸煮浓缩后过滤制得。
本实施例涉及的火龙果皮组合物口服剂的具体制备工艺为：
(1)火龙果皮预处理：将鲜火龙果皮洗净，控温20℃内用粉碎机粉碎成浆液，然后将浆液与重量百分比浓度35％的乙醇水溶液按1:5重量比混合，搅拌均匀，控温20℃内静置30-36小时，静置过程中每隔5小时搅拌一次，得混合浆液；
(2)老酒浆液制备：将3-5成熟的鲜苘麻籽包在常温常压下与30-40℃的温水按1:1的重量比混合，然后放入果汁机中粉碎成苘麻籽包浆液，最后向苘麻籽包浆液中加入苘麻籽包浆液3倍重量的即墨老酒，搅拌均匀，制得老酒浆液；
(3)玉米汁制备：取6-7成熟的鲜玉米粒控温90-100℃蒸煮5-6分钟到煮熟，再将散发出清香的熟玉米粒迅速放入0-10℃的冷水中冷却，然后将冷却后的熟玉米粒与水按1:2重量配比混合后放入粉碎机中粉碎成玉米浆液，最后将玉米浆液用120目筛网过滤得滤液，即为玉米汁；
(4)玉米须液制备：取新鲜玉米须清洗干净后放入烘箱中控温100-120℃烘烤20-30分钟，取出烘干的玉米须冷却后用研磨机研磨成粉，过200目筛网制得玉米须粉，将玉米须粉与水按1:50的重量配比放入铁锅中大火熬制，煮沸后熬制20-30分钟至溶液总体积缩减至原总体积的1/2，将蒸煮液冷却后过滤，收取滤液即为玉米须液；
(5)组合物混合液制备：在常温无氧环境下取混合浆液、老酒浆液、蜂蜜、玉米汁和玉米须液按15-20:5-6:2:6-8:10-15重量比搅拌混合均匀，控温15-20℃密封存储，制得组合物混合液；
(6)火龙果皮组合物口服剂制备：将组合物混合液放入反应锅中控温20℃内在1.3-1.6KPa条件下减压蒸馏，收取乙醇并回收利用，当组合物混合液中乙醇浓度蒸馏至低于重量百分比浓度2％时，停止蒸馏制得火龙果皮组合物口服剂，在常温无氧环境下密封保存。
本实施例涉及的火龙果皮组合物口服剂含有丰富的花青素，具有抗氧化、抗自由基、抗衰老的作用，美容养颜；患有假性近视的8-12岁小学生每日服用一次，每次服用20-30g，4-6个月后视力明显改善；所述火龙果皮组合物口服剂还能够预防贫血和抗神经炎及口角炎等炎症具有良好的效果，是一种营养价值极高的保健食品。
实施例3
本实施例采用实施例1和实施例2制备的火龙果皮组合物口服剂在青岛大学附属医院进行五组临床试验，每组有10人参与，其中对照组的应用对象(普通人员)包括5名老年人和5名青年人，经过6个月的临床试验得到如下数据：
分析上表可知，实施例1和2制备的产品对老年人的心脏具有调节功能，同时对降低心率有良好效果，并且对青年人的视力改善明显，但对老年人的视力改善并无明显效果；与不服用本实施例产品的对比组相比，实施例1和2制备的产品的营养作用显著。
Claims (3)
1.一种火龙果皮组合物口服剂，其特征在于：其各原料重量配比为：混合浆液：老酒浆液：蜂蜜：玉米须液＝10:5-6:2:10-15；其中混合浆液由火龙果皮浆液与重量百分比浓度35％的乙醇水溶液按1:5重量比制得，老酒浆液由苘麻籽包浆液与即墨老酒按1:3的重量配比混合制得，玉米须液由玉米须粉与水按1:50重量配比蒸煮浓缩后过滤制得；所述的火龙果皮为鲜质的红色火龙果去肉后的皮层物，所述的鲜苘麻籽包为苘麻开花后10-20天期间内形成的伞状鲜质苘麻籽带壳包。
2.根据权利要求1所述的火龙果皮组合物口服剂，其特征在于：所述的火龙果皮组合物口服剂的具体制备工艺为：
(1)火龙果皮预处理：将鲜火龙果皮洗净，控温20℃内用粉碎机粉碎成浆液，然后将浆液与重量百分比浓度35％的乙醇水溶液按1:5重量比混合，搅拌均匀，控温20℃内静置30-36小时，静置过程中每隔5小时搅拌一次，得混合浆液；
(2)老酒浆液制备：将3-5成熟的鲜苘麻籽包在常温常压下与30-40℃的温水按1:1的重量比混合，然后放入果汁机中粉碎成苘麻籽包浆液，最后向苘麻籽包浆液中加入苘麻籽包浆液3倍重量的即墨老酒，搅拌均匀，制得老酒浆液；
(3)玉米须液制备：取新鲜玉米须清洗干净后放入烘箱中控温100-120℃烘烤20-30分钟，取出烘干的玉米须冷却后用研磨机研磨成粉，过200目筛网制得玉米须粉，将玉米须粉与水按1:50的重量配比放入铁锅中大火熬制，煮沸后熬制20-30分钟至溶液总体积缩减至原总体积的1/2，将蒸煮液冷却后过滤，收取滤液即为玉米须液；
(4)组合物混合液制备：在常温无氧环境下取混合浆液、老酒浆液、蜂蜜和玉米须液按10:5-6:2:10-15重量比搅拌混合均匀，控温15-20℃密封存储，制得组合物混合液；
(5)火龙果皮组合物口服剂制备：将组合物混合液放入反应锅中控温20℃内在1.3-1.6KPa条件下减压蒸馏，收取乙醇并回收利用，当组合物混合液中乙醇浓度蒸馏至低于重量百分比浓度1％时，停止蒸馏制得火龙果皮组合物口服剂，在常温无氧环境下密封保存。
3.根据权利要求1所述的火龙果皮组合物口服剂，其特征在于：所述的火龙果组合物口服剂能够用于调节血压，高血压患者每日服用三次，每次直接口服20-40g,2-3周后血压控制良好，6-8周后，82％的高血压患者情况明显改善。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018111844793 | 2018-10-11 | ||
| CN201811184479.3A CN109363172A (zh) | 2018-10-11 | 2018-10-11 | 一种火龙果皮组合物口服剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110169577A true CN110169577A (zh) | 2019-08-27 |
Family
ID=65403619
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811184479.3A Pending CN109363172A (zh) | 2018-10-11 | 2018-10-11 | 一种火龙果皮组合物口服剂 |
| CN201910640462.2A Pending CN110169577A (zh) | 2018-10-11 | 2019-07-15 | 一种火龙果皮组合物口服剂 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811184479.3A Pending CN109363172A (zh) | 2018-10-11 | 2018-10-11 | 一种火龙果皮组合物口服剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN109363172A (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102885365A (zh) * | 2011-07-20 | 2013-01-23 | 曲直 | 一种玉米须提取物保健品 |
| CN103845581A (zh) * | 2012-12-06 | 2014-06-11 | 冷雪飞 | 一种天然绿色组合物及其预防治疗糖尿病的应用 |
| CN105995308A (zh) * | 2016-05-24 | 2016-10-12 | 蚌埠鲲鹏食品饮料有限公司 | 一种桂花香味辅助降血压功效的玉米须保健饮料 |
| CN106819724A (zh) * | 2016-12-19 | 2017-06-13 | 蚌埠鲲鹏食品饮料有限公司 | 一种营养保健山麻楂饮料 |
| CN107183433A (zh) * | 2017-06-09 | 2017-09-22 | 百色学院 | 一种火龙果果汁及其加工方法 |
| CN107574109A (zh) * | 2017-09-24 | 2018-01-12 | 礼泉县御品种植养殖专业合作社 | 一种火龙果皮饮料的制备方法 |
-
2018
- 2018-10-11 CN CN201811184479.3A patent/CN109363172A/zh active Pending
-
2019
- 2019-07-15 CN CN201910640462.2A patent/CN110169577A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102885365A (zh) * | 2011-07-20 | 2013-01-23 | 曲直 | 一种玉米须提取物保健品 |
| CN103845581A (zh) * | 2012-12-06 | 2014-06-11 | 冷雪飞 | 一种天然绿色组合物及其预防治疗糖尿病的应用 |
| CN105995308A (zh) * | 2016-05-24 | 2016-10-12 | 蚌埠鲲鹏食品饮料有限公司 | 一种桂花香味辅助降血压功效的玉米须保健饮料 |
| CN106819724A (zh) * | 2016-12-19 | 2017-06-13 | 蚌埠鲲鹏食品饮料有限公司 | 一种营养保健山麻楂饮料 |
| CN107183433A (zh) * | 2017-06-09 | 2017-09-22 | 百色学院 | 一种火龙果果汁及其加工方法 |
| CN107574109A (zh) * | 2017-09-24 | 2018-01-12 | 礼泉县御品种植养殖专业合作社 | 一种火龙果皮饮料的制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 何平: "《眉山中草药资源一图鉴（上）》", 30 September 2016, 四川科学技术出版社 * |
| 杨卫平等: "《特色中草药及配方．2》", 31 August 2016, 贵州科技出版社 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109363172A (zh) | 2019-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101416735B (zh) | 一种营养滋补蜜枣罐头及其制备方法 | |
| CN102408974B (zh) | 一种含大豆异黄酮的黑米酒的制备方法 | |
| CN104673594B (zh) | 一种甜茶酒的生产方法 | |
| CN109315576A (zh) | 纳豆竹叶黄酮压片糖果 | |
| CN106118999A (zh) | 一种猕猴桃果酒的酿制方法 | |
| CN107937207A (zh) | 一种地稔保健果酒及其制备工艺 | |
| KR101812725B1 (ko) | 홍삼을 포함하는 생약재를 이용한 환의 제조방법 및 그에 의해 제조된 홍삼을 포함하는 생약재를 이용한 환 | |
| CN107198103A (zh) | 一种奇效杂粮营养粉及其制备方法 | |
| CN106173895A (zh) | 一种防衰老可冲食杂粮面粉及其制作方法 | |
| CN108410635A (zh) | 一种圣女果果酒的酿造方法 | |
| CN103598286A (zh) | 一种绞股蓝营养保健面包 | |
| CN114259012A (zh) | 一种胡杨碱配方面粉及其制备方法 | |
| CN110169577A (zh) | 一种火龙果皮组合物口服剂 | |
| CN110226753A (zh) | 一种火龙果皮组合物口服剂的制备方法 | |
| CN110179111A (zh) | 一种火龙果皮保健口服液的制备方法 | |
| CN110179110A (zh) | 一种火龙果皮保健口服液 | |
| CN110240995A (zh) | 一种苦荞红曲枸杞养生醋及其生产工艺 | |
| CN105831511A (zh) | 一种苎麻养生粉制备工艺 | |
| CN104351300A (zh) | 养颜排毒饼干及其制备方法 | |
| CN104642904A (zh) | 馒头的制作方法 | |
| CN103583628A (zh) | 一种蓝莓叶营养保健面包 | |
| CN104026357A (zh) | 一种易消化高蛋白猪饲料及其制备方法 | |
| CN103602548A (zh) | 一种何首乌红景天山药桑葚枸杞复合发酵中草药保健酒 | |
| CN108850380A (zh) | 一种枸杞咖啡的配方及制备方法 | |
| CN108029937A (zh) | 一种金钗石斛汁糯米糍及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190827 |